Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$27,000.00

Aromatase Inhibitor Therapy and Arterial Stiffness in Post-Menopausal Breast Cancer Survivors

EF 2024-25

Résumé
Breast cancer (BC) survivors are at 2-6 times the risk of dying from cardiovascular disease (CVD) compared to women without BC, with this risk rising across 10 years after BC diagnosis. Nearly half of the women who have a BC diagnosis will be prescribed aromatase inhibitor (AI) therapy, a form of endocrine therapy for 5-10 years; however, AIs are associated with increased risk of CVD events. There is some evidence that arterial stiffness, an established risk marker for CVD, increases with AI therapy; though the results are limited to one small study. Arterial stiffness is also strongly influenced by aging, thus the time since diagnosis and initiating AI therapy may also be important factors in CVD risk. The first purpose of this study is to compare arterial stiffness between AI-treated post-menopausal BC survivors and non-cancer controls. The second purpose of this study is to determine the relationship between time since BC diagnosis and arterial stiffness among BC survivors on AI therapy. I hypothesize that arterial stiffness will be higher in BC survivors, with more stiffness being noted with increasing time since diagnosis. I will recruit 60 BC survivors who are ~1-10 years post-diagnosis and will match each survivor 1-on-1 on age and body composition to a control without cancer (60 total). Central and peripheral arterial stiffness will be assessed using pulse wave velocity (PWV) in between arteries in the body, and in the heart. The findings from this research will characterize the long-term changes to vessel structure that contribute to an increased risk of CVD in BC survivors and will open new avenues for research to consider post-therapy CVD management, including exercise- and diet-based management strategies to improve long-term cardiovascular health outcomes.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
530154
Name
Zaheer Aida
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Aromatase Inhibitor Therapy and Arterial Stiffness in Post-Menopausal Breast Cancer Survivors
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aromatase Inhibitors; Arterial Stiffness; Breast Cancer; Pulse Wave Velocity
Abstract
Breast cancer (BC) survivors are at 2-6 times the risk of dying from cardiovascular disease (CVD) compared to women without BC, with this risk rising across 10 years after BC diagnosis. Nearly half of the women who have a BC diagnosis will be prescribed aromatase inhibitor (AI) therapy, a form of endocrine therapy for 5-10 years; however, AIs are associated with increased risk of CVD events. There is some evidence that arterial stiffness, an established risk marker for CVD, increases with AI therapy; though the results are limited to one small study. Arterial stiffness is also strongly influenced by aging, thus the time since diagnosis and initiating AI therapy may also be important factors in CVD risk. The first purpose of this study is to compare arterial stiffness between AI-treated post-menopausal BC survivors and non-cancer controls. The second purpose of this study is to determine the relationship between time since BC diagnosis and arterial stiffness among BC survivors on AI therapy. I hypothesize that arterial stiffness will be higher in BC survivors, with more stiffness being noted with increasing time since diagnosis. I will recruit 60 BC survivors who are ~1-10 years post-diagnosis and will match each survivor 1-on-1 on age and body composition to a control without cancer (60 total). Central and peripheral arterial stiffness will be assessed using pulse wave velocity (PWV) in between arteries in the body, and in the heart. The findings from this research will characterize the long-term changes to vessel structure that contribute to an increased risk of CVD in BC survivors and will open new avenues for research to consider post-therapy CVD management, including exercise- and diet-based management strategies to improve long-term cardiovascular health outcomes.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zaheer, Aida
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~